UniProt/SwissProt ID: | PCNA_HUMAN |
Description: | proliferating cell nuclear antigen [Source:HGNC Symbol;Acc:8729] |
Location: | chr20 p12.3 |
Node attribute: | PPI(target); gene |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S261 | EDEEGs_____ | PhosphoSitePlus | |
Y211 | TFALRyLNFFT | PCNA_C | PhosphoSitePlus |
Y250 | GHLKYyLAPKI | HPRD; SysPTM | |
Dephosphorylation site |
PCNA_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000368438 | I88V | COSMIC | Lung Cancer | |
ENSP00000368458 | I88V | COSMIC | Lung Cancer | |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000368458 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 9.1 | 15759316 |
ENSP00000368458 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 3 | 17627933 |
ENSP00000368458 | Breast Cancer | Treatment (chemosensitive vs. paclitaxel-resistant) | cell line | Up | 2.2 | 17487377 |
ENSP00000368458 | Breast Cancer | Treatment (none vs. 17b-Estradiol treatment) | cell line | Up | 3.5 | 18491314 |
ENSP00000368458 | hepatitis B virus | Treatment (none vs tetracycline-treatment) | cell line | Up | 2 | 19671925 |
ENSP00000368458 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 18937283 | |
ENSP00000368458 | Non-small cell lung carcinoma | Normal vs. Cancer | cell line | Up | 15359725 | |
ENSP00000368458 | Breast Cancer | Metastasis | cell line | Up | 1.2 | 18582095 |
ENSP00000368458 | Breast Cancer | Normal vs. Cancer | tissue | Up | >10 | 20005186 |
ENSP00000368458 | Oral Cancer | Normal vs. Cancer | tissue | Up | 8 | 19691830 |
ENSP00000368458 | Leukemia | Normal vs. Cancer | tissue | Up | 15501966 | |
ENSP00000368458 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Up | 11 | 17655343 |
ENSP00000368458 | Ovarian Cancer | Treatment (chemotherapy-sensitive vs. chemotherapy-resistant) | tissue | Down | 0.5 | 19422301 |
ENSP00000368458 | Gastric Cancer | Normal vs. Cancer | tissue | Up | 20677338 | |
ENSP00000368458 | Uterine Cancer | Normal vs. Cancer | cell line | Up | 430 | 15838902 |
Hyperphosphorylation site |
PCNA_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
GA45G_HUMAN | PCNA_HUMAN | other | KEGG |
RFX1_HUMAN | PCNA_HUMAN | TF -> target gene | TRANSFAC |
P53_HUMAN | PCNA_HUMAN | TF -> target gene | TRANSFAC |
E2F4_HUMAN | PCNA_HUMAN | TF -> target gene | TRANSFAC |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa03430 | Mismatch repair |
hsa04110 | Cell cycle |
hsa03030 | DNA replication |
hsa03410 | Base excision repair |
hsa05166 | HTLV-I infection |
hsa03420 | Nucleotide excision repair |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0006283 | transcription-coupled nucleotide-excision repair | TAS | biological_process |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0032201 | telomere maintenance via semi-conservative replica | TAS | biological_process |
GO:0000083 | regulation of transcription involved in G1/S phase | TAS | biological_process |
GO:0007507 | heart development | IEA | biological_process |
GO:0006260 | DNA replication | NAS | biological_process |
GO:0005634 | nucleus | IEA | cellular_component |
GO:0000082 | G1/S transition of mitotic cell cycle | TAS | biological_process |
GO:0030971 | receptor tyrosine kinase binding | IPI | molecular_function |
GO:0043626 | PCNA complex | IEA | cellular_component |
GO:0030337 | DNA polymerase processivity factor activity | IEA | molecular_function |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0019985 | translesion synthesis | IDA | biological_process |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0008283 | cell proliferation | TAS | biological_process |
GO:0000084 | S phase of mitotic cell cycle | TAS | biological_process |
GO:0006284 | base-excision repair | TAS | biological_process |
GO:0006289 | nucleotide-excision repair | TAS | biological_process |
GO:0006281 | DNA repair | NAS | biological_process |
GO:0000278 | mitotic cell cycle | TAS | biological_process |
GO:0032405 | MutLalpha complex binding | IDA | molecular_function |
GO:0030896 | checkpoint clamp complex | IEA | cellular_component |
GO:0046686 | response to cadmium ion | IEA | biological_process |
GO:0003677 | DNA binding | IEA | molecular_function |
GO:0005654 | nucleoplasm | TAS | cellular_component |
GO:0070557 | PCNA-p21 complex | IDA | cellular_component |
GO:0042802 | identical protein binding | IPI | molecular_function |
GO:0006271 | DNA strand elongation involved in DNA replication | TAS | biological_process |
GO:0032077 | positive regulation of deoxyribonuclease activity | IDA | biological_process |
GO:0006298 | mismatch repair | IDA | biological_process |
GO:0048015 | phosphatidylinositol-mediated signaling | NAS | biological_process |
GO:0000723 | telomere maintenance | TAS | biological_process |
GO:0032139 | dinucleotide insertion or deletion binding | IDA | molecular_function |
GO:0005663 | DNA replication factor C complex | TAS | cellular_component |
GO:0006275 | regulation of DNA replication | IEA | biological_process |
GO:0006297 | nucleotide-excision repair, DNA gap filling | TAS | biological_process |
GO:0000701 | purine-specific mismatch base pair DNA N-glycosyla | IDA | molecular_function |
GO:0043596 | nuclear replication fork | IDA | cellular_component |
GO:0005737 | cytoplasm | IDA | cellular_component |
GO:0033993 | response to lipid | IEA | biological_process |
GO:0000722 | telomere maintenance via recombination | TAS | biological_process |
GO:0000077 | DNA damage checkpoint | IEA | biological_process |
GO:0015630 | microtubule cytoskeleton | IDA | cellular_component |